Design Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q2 2024 | 2 | -$0.27 | -$0.22 | -$0.24 |
| Q3 2024 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q1 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q2 2025 | 1 | -$0.28 | -$0.28 | -$0.28 |
| Q3 2025 | 1 | -$0.29 | -$0.29 | -$0.29 |
| Q4 2025 | 1 | -$0.30 | -$0.30 | -$0.30 |
Design Therapeutics, Inc. Earnings Date And Information
Design Therapeutics, Inc. last posted its earnings results on Monday, August 5th, 2024. The company reported $-0.21 earnings per share for the quarter, topping analysts' consensus estimates of $-0.25 by $0.04. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Design Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.19 diluted earnings per share) and currently has a price-to-earnings ratio of -6.22. Design Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based on prior year's report dates.
Design Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/05/2024 | Q2 2024 | -$0.25 | -$0.21 | 0.04 | $0 | $0 |
| 05/08/2024 | Q1 2024 | -$0.28 | -$0.20 | 0.08 | $0 | |
| 03/19/2024 | Q4 2023 | -$0.32 | -$0.21 | 0.11 | $838,000 | |
| 11/13/2023 | Q3 2023 | -$0.42 | -$0.28 | 0.14 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.41 | -$0.36 | 0.05 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.37 | -$0.30 | 0.07 | $0 | |
| 03/14/2023 | Q4 2022 | -$0.34 | -$0.27 | 0.07 | $0 | |
| 11/03/2022 | Q3 2022 | -$0.28 | -$0.29 | -0.01 | $0 | |
| 08/08/2022 | Q2 2022 | -$0.25 | -$0.26 | -0.01 | $0 | |
| 05/09/2022 | Q1 2022 | -$0.22 | -$0.24 | -0.02 | $0 | |
| 03/10/2022 | Q4 2021 | -$0.22 | -$0.20 | 0.02 | $0 | |
| 11/09/2021 | Q3 2021 | -$0.14 | -$0.21 | -0.07 | $0 | |
| 08/09/2021 | Q2 2021 | -$0.18 | -$0.14 | 0.04 | $0 | |
| 05/10/2021 | Q1 2021 | -$0.07 | -$0.31 | -0.24 | $0 | |
| 12/30/2020 | Q4 2020 | -$0.14 | $33,000 | |||
| 09/29/2020 | Q3 2020 | -$0.09 | $20,000 | |||
| 06/29/2020 | Q2 2020 | -$0.05 | $31,000 | |||
| 03/30/2020 | Q1 2020 | -$0.02 | $142,000 |
Design Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Design Therapeutics, Inc.'s earnings date?
Design Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based off last year's report dates.
-
Did Design Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Design Therapeutics, Inc. (:DSGN) reported $-0.21 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.25 by $0.04.
-
How can I listen to Design Therapeutics, Inc.'s earnings conference call?
The conference call for Design Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Design Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Design Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Design Therapeutics, Inc. generate each year?
Design Therapeutics, Inc. (:DSGN) has a recorded net income of $0. Design Therapeutics, Inc. has generated $-1.19 earnings per share over the last four quarters.
-
What is Design Therapeutics, Inc.'s price-to-earnings ratio?
Design Therapeutics, Inc. (:DSGN) has a price-to-earnings ratio of -6.22 and price/earnings-to-growth ratio is -0.44.
